Correlation Between Acrivon Therapeutics, and PepGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and PepGen, you can compare the effects of market volatilities on Acrivon Therapeutics, and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and PepGen.

Diversification Opportunities for Acrivon Therapeutics, and PepGen

AcrivonPepGenDiversified AwayAcrivonPepGenDiversified Away100%
0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Acrivon and PepGen is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and PepGen go up and down completely randomly.

Pair Corralation between Acrivon Therapeutics, and PepGen

Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 66.39 times less return on investment than PepGen. But when comparing it to its historical volatility, Acrivon Therapeutics, Common is 3.12 times less risky than PepGen. It trades about 0.01 of its potential returns per unit of risk. PepGen is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  184.00  in PepGen on November 30, 2024 and sell it today you would earn a total of  59.00  from holding PepGen or generate 32.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Acrivon Therapeutics, Common  vs.  PepGen

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -80-60-40-2002040
JavaScript chart by amCharts 3.21.15ACRV PEPG
       Timeline  
Acrivon Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb55.566.577.58
PepGen 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PepGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb23456

Acrivon Therapeutics, and PepGen Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-9.31-6.98-4.64-2.3-0.0382.244.536.819.09 0.0040.0060.0080.0100.012
JavaScript chart by amCharts 3.21.15ACRV PEPG
       Returns  

Pair Trading with Acrivon Therapeutics, and PepGen

The main advantage of trading using opposite Acrivon Therapeutics, and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.
The idea behind Acrivon Therapeutics, Common and PepGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing